News

Published on 3 Feb 2024 on GuruFocus.com via Yahoo Finance

Baillie Gifford Reduces Stake in Denali Therapeutics Inc

Article preview image

Overview of Baillie Gifford (Trades, Portfolio)'s Recent Stock Transaction

Warning! GuruFocus has detected 2 Warning Sign with DNLI.

Baillie Gifford (Trades, Portfolio), a renowned investment management firm, has recently adjusted its investment in Denali Therapeutics Inc (NASDAQ:DNLI), a biotechnology company focused on defeating neurodegenerative diseases. On December 1, 2023, the firm executed a reduction in its holdings of Denali Therapeutics' shares, signaling a strategic shift in its investment portfolio.

Read the rest of the article
NASDAQ.DNLI price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
DNLI's Hunter Syndrome Drug Gets Breakthrough Therapy Designation

Denali obtains Breakthrough Therapy Designation for its experimental candidate, tividenofusp alfa...

Zacks · via Yahoo Finance 9 Jan 2025
Why biotech startup Tenvie sees promise in drugs from founders' old company -...

A Peninsula biotech startup didn't look far to find a cache of drugs and the cash it needs to...

The Business Journals 9 Jan 2025
Denali Therapeutics CEO Ryan Watts sells $750,955 in stock By Investing.com

Denali Therapeutics CEO Ryan Watts sells $750,955 in stock

Investing.com 8 Jan 2025
Denali Therapeutics' Amyotrophic Lateral Sclerosis Misses Pivotal Trial, But...

On Monday, Denali Therapeutics Inc. (NASDAQ:DNLI) revealed topline results from an analysis of...

Benzinga · via Yahoo Finance 7 Jan 2025
Denali Therapeutics Inc. (DNLI): Jeff Bezos Is Buying This Stock Now

We recently compiled a list of the 8 Stocks Jeff Bezos is Buying. In this article, we are going t...

Insider Monkey · via Yahoo Finance 14 Oct 2024
Is There An Opportunity With Denali Therapeutics Inc.'s (NASDAQ:DNLI) 50% Undervaluation?

Key Insights Using the 2 Stage Free Cash Flow to Equity, Denali Therapeutics fair value estimate ...

Simply Wall St. via Yahoo Finance 29 Apr 2024
Denali Therapeutics Inc (DNLI) Reports Full Year and Q4 2023 Financial Results

Net Loss: Reported a net loss of $119.5 million for Q4 and $145.2 million for the full year 2023....

GuruFocus.com via Yahoo Finance 27 Feb 2024
Baillie Gifford Reduces Stake in Denali Therapeutics Inc

Overview of Baillie Gifford (Trades, Portfolio)'s Recent Stock Transaction Warning! GuruFocus has...

GuruFocus.com via Yahoo Finance 3 Feb 2024
Does Denali Therapeutics Inc. (DNLI) Have the Potential to Rally 123.38% as Wall Street Analysts...

Denali Therapeutics Inc. (DNLI) closed the last trading session at $21.17, gaining 17% over the p...

Zacks via Yahoo Finance 21 Dec 2023
Why Is Denali Therapeutics Inc. (DNLI) Down 5.2% Since Last Earnings Report?

It has been about a month since the last earnings report for Denali Therapeutics Inc. (DNLI). Sha...

Zacks via Yahoo Finance 8 Dec 2023

Copyright Statfolio @ 2025

Social Accounts